| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-05-22 | NCT07604896 Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through… | Phase 4 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07604896 | Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through… | Alzheimer s Disease | Recruiting |
| Phase 3 | |||
| NCT06384573 | DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease | Alzheimer's Disease | Active, Not Recruiting |
| NCT03887455 | A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early… | Early Alzheimer's Disease | Active, Not Recruiting |
| NCT04468659 | AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in… | Preclinical Alzheimer's Disease | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study… | Alzheimers Disease | Active, Not Recruiting |
| NCT05269394 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study… | Alzheimers Disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT06602258 | A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early… | Alzheimer's Disease | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT05469009 | Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive… | Mild Cognitive Impairment | Active, Not Recruiting |
| Not specified | |||
| NCT05999084 | Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry | Alzheimer Disease | Recruiting |
| NCT05925621 | Cognitive Neurology Unit Clinical Registry | Alzheimer Disease | Recruiting |
| NCT06285448 | Feasibility of Lecanemab Registry and Clinical Outcome Measures | Alzheimer Disease | Enrolling by Invitation |
| NCT07505095 | Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in… | Alzheimer Disease (AD) | Not Yet Recruiting |
| NCT07544953 | Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology | Parkinson Disease | Not Yet Recruiting |